Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bioinformatics Analysis Protocol for Host Transcriptomic Profiling of Influenza A Virus Pneumonia Using the GSE40012 Microarray Dataset.

Created on 17 Nov 2026

Authors

Chengqing Zheng, Fang Zhou, Lihui Chen, Bin Jia

Published in

Journal of visualized experiments : JoVE. Issue 237. Nov 10, 2026. Epub Nov 10, 2026.

Abstract

Influenza A virus (IAV) pneumonia triggers severe respiratory injury and disordered host immune-metabolic responses, lacking reliable transcriptomic biomarkers and targeted immunotherapy schemes. This work constructs a complete repeatable analytical pipeline based on R language to mine public Gene Expression Omnibus (GEO) microarray data (dataset ID: GSE40012). The workflow screens differentially expressed genes (DEGs) with cutoffs |log₂(fold change)| > 1 and false discovery rate (FDR) < 0.05, performs Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, conducts pairwise Pearson correlation analysis of core marker genes, and applies Wilcoxon rank-sum tests to compare expression levels of 10 canonical immune checkpoint genes between patient and healthy cohorts. A total of 359 statistically significant DEGs are identified, among which IFI27, DEFA1, DEFA3, HP and MCEMP1 are the most significantly upregulated biomarkers. Upregulated transcripts are enriched in innate immunity and mitochondrial oxidative phosphorylation pathways, while downregulated genes concentrate on T cell differentiation and T cell receptor signaling cascades. Five immune checkpoint molecules, including CD274 (PD-L1) and TIGIT, show significant intergroup differential expression between IAV pneumonia and healthy samples. This reproducible analytical workflow identifies transcriptional patterns associated with innate and adaptive immune responses and provides a framework for exploratory biomarker screening in IAV pneumonia.

PMID:
43042876
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement